PMID- 12734208 OWN - NLM STAT- MEDLINE DCOM- 20030814 LR - 20220711 IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 278 IP - 28 DP - 2003 Jul 11 TI - Increased production of 12/15 lipoxygenase eicosanoids accelerates monocyte/endothelial interactions in diabetic db/db mice. PG - 25369-75 AB - Atherosclerosis is a major complication of diabetes. Up to 16 weeks of age, the db/db mouse is insulin-resistant and hyperglycemic and is a good model of Type 2 diabetes. After approximately 16 weeks of age, the mice develop pancreatic beta cell failure that can progress to a Type 1 diabetes phenotype. We have previously shown that glucose increases production of endothelial 12/15 lipoxygenase (12/15LO) products in vitro. In young 10-week-old Type 2 diabetic db/db mice, we found significant elevations in levels of urinary 12/15LO products, 12S-hydroxyeicosatetraenoic acid (12S-HETE) and 13S-hydroxyoctadecaenoic acid (13S-HODE) in vivo compared with C57BLKS/J mice. Using isolated primary aortic endothelial cells (ECs) from db/db mice and WEHI78/24 mouse monocyte cells in static adhesion assays, we found increased WEHI monocyte adhesion to db/db ECs (14 +/- 2 monocytes/field for db/db ECs versus 4 +/- 1 monocytes/field for C57BLKS/J ECs, p < 0.002). Thus, ECs from db/db mice appear to be "pre-activated" to bind monocytes. Analysis of db/db ECs revealed a 2-fold elevation in 12/15LO protein compared with C57BLKS/J EC. To determine that 12/15LO products were responsible for the increased monocyte adhesion observed with db/db ECs, we inhibited expression of murine 12/15LO using either an adenovirus expressing a ribozyme to 12/15LO (AdRZ) or with the 12/15LO inhibitor cinnamyl-3,4-dihydroxy-alpha-cyanocinnamate. Treatment of db/db ECs for 48 h with AdRZ or 4 h with 10 microm cinnamyl-3,4-dihydroxy-alpha-cyanocinnamate significantly reduced monocyte adhesion to db/db endothelium (p < 0.009). Thus, inhibition of the murine 12/15LO in db/db mice significantly reduced monocyte/endothelial interactions. We also found that adhesion of monocytes to diabetic db/db ECs was mediated by interactions of alpha4beta1 integrin on monocytes with endothelial vascular cell adhesion molecule 1 and connecting segment 1 fibronectin and interactions of beta2 integrins with endothelial intercellular adhesion molecule 1. In summary, regulation of the 12/15LO pathway is important for mediating early vascular changes in diabetes. Modulation of the 12/15LO pathway in the vessel wall may provide therapeutic benefit for early vascular inflammatory events in diabetes. FAU - Hatley, Melissa E AU - Hatley ME AD - Division of Endocrinology and Metabolism and Cardiovascular Research Center, University of Virginia, Charlottesville, Virginia 22908, USA. FAU - Srinivasan, Suseela AU - Srinivasan S FAU - Reilly, Kelly B AU - Reilly KB FAU - Bolick, David T AU - Bolick DT FAU - Hedrick, Catherine C AU - Hedrick CC LA - eng GR - DK39721/DK/NIDDK NIH HHS/United States GR - P01 HL55798-06/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. DEP - 20030506 PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (Eicosanoids) RN - 0 (Fibronectins) RN - 0 (Linoleic Acids) RN - 0 (Reactive Oxygen Species) RN - 5204-88-6 (13-hydroxy-9,11-octadecadienoic acid) RN - 59985-28-3 (12-Hydroxy-5,8,10,14-eicosatetraenoic Acid) RN - EC 1.13.11.31 (Arachidonate 12-Lipoxygenase) RN - EC 1.13.11.33 (Arachidonate 15-Lipoxygenase) SB - IM EIN - J Biol Chem. 2003 Dec 12;278(50):50818 MH - 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid/urine MH - Animals MH - Aorta/metabolism MH - Arachidonate 12-Lipoxygenase/*biosynthesis MH - Arachidonate 15-Lipoxygenase/*biosynthesis MH - Cell Adhesion MH - Eicosanoids/metabolism MH - Endothelium, Vascular/*metabolism MH - Fibronectins/metabolism MH - Flow Cytometry MH - Immunoassay MH - Inflammation MH - Islets of Langerhans/metabolism MH - Linoleic Acids/urine MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Mitochondria/metabolism MH - Monocytes/*metabolism MH - Phenotype MH - Reactive Oxygen Species EDAT- 2003/05/08 05:00 MHDA- 2003/08/15 05:00 CRDT- 2003/05/08 05:00 PHST- 2003/05/08 05:00 [pubmed] PHST- 2003/08/15 05:00 [medline] PHST- 2003/05/08 05:00 [entrez] AID - S0021-9258(19)75048-0 [pii] AID - 10.1074/jbc.M301175200 [doi] PST - ppublish SO - J Biol Chem. 2003 Jul 11;278(28):25369-75. doi: 10.1074/jbc.M301175200. Epub 2003 May 6.